Sponsors / CROs

Twenty-four FDA Approvals

approved drugs
  • EYSUVIS® (Kala)
  • Durysta™ (Allergan)
  • iStent® (Glaukos)
  • Xiidra® (Shire)
  • Hydrus IV® (Ivantis)
  • True Tear® (Allergan)
  • Rhopressa® (Aerie)
  • Inveltys® (Kala)
  • Lumigan® (Allergan)
  • Lotemax® (Baush + Lomb)
  • Vexol® (Alcon)
  • Visudyne® (Baush + Lomb)
  • Vuity™ (Allergan/ AbbVie)
  • Tyrvaya™
  • Dextenza®
  • AEYE-DS Tool
  • Canalicular Occlusive Device created by Vistant Medical
  • Vevye ® (Novaliq GmbH) 
  • XDEMVY™ (Tarsus) 
  • Qlosi™ (Orasis)
  • Clobetasol propionate ophthalmic solution 0.05% (Formosa)
  • Lumify ® PF (Bausch + Lomb)
  • TRYPTYR® Eye Drops
  • VIZZ™

Decades of Clinical Trials Experience

  • Global IRB preferred
  • Contract and budget approval average time is less than ten days
  • A freestanding clinical trial building on our 5-acre medical campus
  • Dedicated office space for monitors with high-speed internet access
  • Twenty-four trial drugs with FDA approval
  • Seven Principal Investigators
  • A national reputation as a superior, compliant, high-enrolling ophthalmic trials site
  • Experienced site with over 460 trials completed
  • Nine full-time clinical trials staff members
  • Data-rich ophthalmic EMR access to over 80,000 patients with all conditions allowing Butchertown Clinical Trials to recruit for any Adult Medicine, Metabolic, Nutrition, Cancer Genomics, and Vaccine studies.

Top-Notch Data Integrity

data integrity
  • Our data is valid, auditable, and accurate. Our site has never been issued with any FDA findings.
  • With our patient databases, MDI Intellichart™, Nextech™ scheduling software, and RealTime clinical trial management software, we can search 80,000 active patient charts to easily search for potential subjects by condition, disease, and inclusion / exclusion criteria.
  • In the past two years alone, we have participated in 37 clinical and surgical trials including both drug and device trials.
  • Our sponsor and CRO list include Allergan, Alcon Research, Bausch and Lomb, Tarsus, ORA, Novartis, Kala, IQVIA, Lexitas, and Veristat, just to name a few.

Watch Our Demo Video

Learn about RealTime-CTMS and Nextech Systems to learn why sponsors & CROs Trust Butchertown Clinical Trials.

Development Stage Full-Service Clinical Trials

Our rich database and a stellar community reputation allow us to recruit our adult patients to participate in trials for many diseases and conditions with 80,000 total patients in database, including:

  • 40,000 Females
  • 31,000 Males
  • 17,000 under age 40
  • 31,000 ages 40 to 69
  • 23,000 over age 65
  • 40,000 Caucasian
  • 6,000 African American
  • 105 Hispanic
  • 680 Asian

Fairness, Inclusion & Belonging in Research

At Butchertown Clinical Trials, we are committed to improving diversity and representation in clinical research. Historically, many communities have been left out or underserved in clinical trials, leading to gaps in trust and unequal health outcomes. We work to bridge that gap by:

  • Reaching underrepresented populations through multilingual, multicultural outreach
  • Following FDA diversity guidelines, including the FDORA requirements
  • Building community trust through ongoing engagement and inclusive recruitment strategies

Located in the heart of diverse Louisville, KY, our team reflects the community we serve. We’re proud to use a broad range of outreach channels to ensure access and awareness.

By making clinical trials more inclusive, we help improve the quality and impact of medical research, for everyone.

diversity

Collaboration for Results

Partner With Us

We recruit Board Certified Internists, Family Practice Physicians, Emergency Medicine Physicians, Certified Diabetic Educators, and more to act as Principal Investigators at our site using our own database of patients.

With these resources and recruitment capabilities, we have the knowledge and skills to successfully recruit and retain subjects for your Phase 2 and Phase 3 trials so you can meet your clinical endpoints.

Partner With Us
partner with us